A who's who of integrity agreements

Share this article:

FDA anger can bring down a corporate integrity agreement on a drug or device maker. Health and Human Services' Office of the Inspector General has a lineup of the pharma companies who are on notice. Of the 20 listed, only one has an end date or has been closed (congratulations, Medtronic).

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.